Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Exercise and Rehabilitation in People With Ehlers-Danlos Syndrome: A Systematic Review.
Buryk-Iggers S, Mittal N, Santa Mina D, Adams SC, Englesakis M, Rachinsky M, Lopez-Hernandez L, Hussey L, McGillis L, McLean L, Laflamme C, Rozenberg D, Clarke H. Buryk-Iggers S, et al. Among authors: mcgillis l. Arch Rehabil Res Clin Transl. 2022 Mar 4;4(2):100189. doi: 10.1016/j.arrct.2022.100189. eCollection 2022 Jun. Arch Rehabil Res Clin Transl. 2022. PMID: 35756986 Free PMC article. Review.
Utilization of the 2017 diagnostic criteria for hEDS by the Toronto GoodHope Ehlers-Danlos syndrome clinic: A retrospective review.
McGillis L, Mittal N, Santa Mina D, So J, Soowamber M, Weinrib A, Soever L, Rozenberg D, Liu L, Tse Y, Katz J, Charames GS, Murphy K, Vadas P, Slepian MP, Walsh S, Wilson L, Adler A, Franzese A, Hussey L, Nevay DL, Guzman J, Clarke H. McGillis L, et al. Am J Med Genet A. 2020 Mar;182(3):484-492. doi: 10.1002/ajmg.a.61459. Epub 2019 Dec 16. Am J Med Genet A. 2020. PMID: 31840928
A review of respiratory manifestations and their management in Ehlers-Danlos syndromes and hypermobility spectrum disorders.
Chohan K, Mittal N, McGillis L, Lopez-Hernandez L, Camacho E, Rachinsky M, Mina DS, Reid WD, Ryan CM, Champagne KA, Orchanian-Cheff A, Clarke H, Rozenberg D. Chohan K, et al. Among authors: mcgillis l. Chron Respir Dis. 2021 Jan-Dec;18:14799731211025313. doi: 10.1177/14799731211025313. Chron Respir Dis. 2021. PMID: 34291699 Free PMC article. Review.
The GoodHope Ehlers Danlos Syndrome Clinic: development and implementation of the first interdisciplinary program for multi-system issues in connective tissue disorders at the Toronto General Hospital.
Mittal N, Mina DS, McGillis L, Weinrib A, Slepian PM, Rachinsky M, Buryk-Iggers S, Laflamme C, Lopez-Hernandez L, Hussey L, Katz J, McLean L, Rozenberg D, Liu L, Tse Y, Parker C, Adler A, Charames G, Bleakney R, Veillette C, Nielson CJ, Tavares S, Varriano S, Guzman J, Faghfoury H, Clarke H. Mittal N, et al. Among authors: mcgillis l. Orphanet J Rare Dis. 2021 Aug 10;16(1):357. doi: 10.1186/s13023-021-01962-7. Orphanet J Rare Dis. 2021. PMID: 34376220 Free PMC article.
The GoodHope Exercise and Rehabilitation (GEAR) Program for People With Ehlers-Danlos Syndromes and Generalized Hypermobility Spectrum Disorders.
Mittal N, Santa Mina D, Buryk-Iggers S, Lopez-Hernandez L, Hussey L, Franzese A, Katz J, Laflamme C, McGillis L, McLean L, Rachinsky M, Rozenberg D, Slepian M, Weinrib A, Clarke H. Mittal N, et al. Among authors: mcgillis l. Front Rehabil Sci. 2021 Nov 8;2:769792. doi: 10.3389/fresc.2021.769792. eCollection 2021. Front Rehabil Sci. 2021. PMID: 36188836 Free PMC article.
Evaluation and Management of Dyspnea in Hypermobile Ehlers-Danlos Syndrome and Generalized Hypermobility Spectrum Disorder: Protocol for a Pilot and Feasibility Randomized Controlled Trial.
Rozenberg D, Al Kaabi N, Camacho Perez E, Nourouzpour S, Lopez-Hernandez L, McGillis L, Goligher E, Reid WD, Chow CW, Ryan CM, Kumbhare D, Huszti E, Champagne K, Raj S, Mak S, Santa Mina D, Clarke H, Mittal N. Rozenberg D, et al. Among authors: mcgillis l. JMIR Res Protoc. 2023 Mar 20;12:e44832. doi: 10.2196/44832. JMIR Res Protoc. 2023. PMID: 36939815 Free PMC article.
Comparable outcomes post allogeneic hematopoietic cell transplant for patients with de novo or secondary acute myeloid leukemia in first remission.
Michelis FV, Atenafu EG, Gupta V, Kim DD, Kuruvilla J, Lipton JH, Loach D, Seftel MD, Uhm J, Alam N, Lambie A, McGillis L, Messner HA. Michelis FV, et al. Among authors: mcgillis l. Bone Marrow Transplant. 2015 Jul;50(7):907-13. doi: 10.1038/bmt.2015.59. Epub 2015 Mar 30. Bone Marrow Transplant. 2015. PMID: 25822226
Patient age, remission status and HCT-CI in a combined score are prognostic for patients with AML undergoing allogeneic hematopoietic cell transplantation in CR1 and CR2.
Michelis FV, Messner HA, Atenafu EG, McGillis L, Lambie A, Uhm J, Alam N, Seftel MD, Gupta V, Kuruvilla J, Lipton JH, Kim DD. Michelis FV, et al. Among authors: mcgillis l. Bone Marrow Transplant. 2015 Nov;50(11):1405-10. doi: 10.1038/bmt.2015.165. Epub 2015 Jul 13. Bone Marrow Transplant. 2015. PMID: 26168067
Modified EBMT Pretransplant Risk Score Can Identify Favorable-risk Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for AML, Not Identified by the HCT-CI Score.
Michelis FV, Messner HA, Uhm J, Alam N, Lambie A, McGillis L, Seftel MD, Gupta V, Kuruvilla J, Lipton JH, Kim DD. Michelis FV, et al. Among authors: mcgillis l. Clin Lymphoma Myeloma Leuk. 2015 May;15(5):e73-81. doi: 10.1016/j.clml.2014.09.014. Epub 2014 Oct 5. Clin Lymphoma Myeloma Leuk. 2015. PMID: 25458081
17 results